Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
REPL
REPL News & Events
-
Add to Watchlist
Trade REPL
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
REPL News
REPLIMUNE GROUP INC: JP MORGAN Downgrades Rating to Underweight from Neutral
Apr 13 2026
moomoo
REPLIMUNE INITIATES IGNYTE-3 IN RESPONSE TO FDA INPUT TO MEET REGULATORY REQUIREMENT FOR CONFIRMATORY STUDY IN ACCELERATED APPROVAL PROCESS
Apr 10 2026
moomoo
Health Care Stocks Decline 1.1% on NYSE
Apr 10 2026
Yahoo Finance
The Short List: Current Top 10 Most Shorted Stocks
Nov 26 2025
Benzinga
Significant Options Activity on Monday: UNH, REPL, CELC
Oct 20 2025
NASDAQ.COM
Most Active Stocks in Pre-Market on October 20, 2025: REPL, RANI, TSLL, SQQQ, BITF, NUAI, ACHR, NIO, BBAI, IONQ, LAC, CLF
Oct 20 2025
NASDAQ.COM
REPLIMUNE UPDATE: Bragar Eagel & Squire, P.C. Launches Investigation into Replimune Group, Inc. for Long-Term Shareholders and Invites Investors to Reach Out to the Firm
Oct 08 2025
Globenewswire
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm
Sep 22 2025
PRnewswire
Show More News
REPL Events
No data
REPL Monitor News
Replimune's Stock Plummets After FDA Rejects RP1 Approval
Apr 13 2026
REPL Earnings Analysis
No Data
People Also Watch
